Peer-influenced content. Sources you trust. No registration required. This is HCN.
Pulmonary Fibrosis News
Discover how engineered stem cells could revolutionize the treatment of chronic lung diseases, including pulmonary fibrosis, by offering a more personalized and sustainable approach.
Pulmonology September 13th 2023
Pharmacy Practice News
Pharmacists, learn more about nirsevimab and how you can help to protect infants from RSV, the leading cause of hospitalization in infants under the age of 1.
Allergy & Immunology August 31st 2023
The New England Journal of Medicine
Uncover the potential of dupilumab in managing COPD patients with type 2 inflammation as this Phase 3 trial reveals fewer exacerbations, improved lung function, and enhanced life quality among the treated cohort.
Allergy & Immunology July 27th 2023
Medical Professionals Reference (MPR)
The FDA’s approval of Beyfortus offers a promising tool for RSV disease prevention in neonates and young children. This novel intervention, underscored by robust clinical trial data, marks a crucial stride towards protecting infant health in the US.
Pediatrics July 27th 2023
American Thoracic Society
Examine the case of a young smoker with acute dyspnea whose chest CT reveals oddly shaped cysts to uncover a mystery that goes beyond usual diagnostics and leads us into the world of uncommon lung disorders.
Pulmonology June 22nd 2023
COPD News Today
Uncover vital insights about supplemental oxygen use, demystify misconceptions, and learn best practices for managing respiratory diseases. Good day, physicians. Let’s talk about the controversial issue of supplemental oxygen use, frequently discussed by patients, clinicians, advocacy groups, and even politicians. In this summary, we’ll untangle misconceptions and illuminate best practices. To start with, the body’s oxygen utilization depends on three things: lung function, heart efficiency, and muscle oxygen use. These factors can improve with exercise, but worsen with inactivity. Remember, exercise matters. Why does oxygen matter? For patients with chronic obstructive pulmonary disease (COPD), pulmonary fibrosis (PF), or pulmonary hypertension (PH), impaired oxygenation can lead to hypoxemia and hypoxia. Hence, supplemental oxygen becomes a necessity. How do we assess oxygen levels? Two tests can be employed: arterial blood gas (ABG) or pulse oximetry. Normal partial pressure of oxygen, as per ABG, is around 75-100 mmHg, and a drop below 60 necessitates supplemental oxygen. Oxygen saturation, measurable via either test, should ideally be 95% or above, and values dropping to 90 or below indicate the need for supplemental oxygen. Now, let’s dispel some myths. Shortness of breath doesn’t always equate to hypoxia. A patient can experience breathlessness even with normal oxygen […]
Family Medicine/General Practice May 24th 2023